Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion type Assertion NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_head.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion description "[Here, we tested whether Polo-like kinase 1 (PLK1) siRNAs complexed with a Her2-ScFv-protamine peptide fusion protein (F5-P) could suppress Her2(+) breast cancer cell lines and primary human cancers in orthotopic breast cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_provenance.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion evidence source_evidence_literature NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_provenance.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion SIO_000772 22517885 NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_provenance.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion wasDerivedFrom befree-2016 NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_provenance.
- NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_assertion wasGeneratedBy ECO_0000203 NP976177.RAaCGXvFBDerdbLXY59-eMU3GDTlRdTo0LjAB1vfb-8II130_provenance.